全文获取类型
收费全文 | 4219篇 |
免费 | 312篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 151篇 |
妇产科学 | 68篇 |
基础医学 | 512篇 |
口腔科学 | 80篇 |
临床医学 | 376篇 |
内科学 | 923篇 |
皮肤病学 | 100篇 |
神经病学 | 260篇 |
特种医学 | 106篇 |
外科学 | 602篇 |
综合类 | 257篇 |
预防医学 | 398篇 |
眼科学 | 114篇 |
药学 | 315篇 |
中国医学 | 31篇 |
肿瘤学 | 205篇 |
出版年
2023年 | 67篇 |
2022年 | 117篇 |
2021年 | 203篇 |
2020年 | 143篇 |
2019年 | 171篇 |
2018年 | 167篇 |
2017年 | 104篇 |
2016年 | 125篇 |
2015年 | 146篇 |
2014年 | 161篇 |
2013年 | 219篇 |
2012年 | 302篇 |
2011年 | 277篇 |
2010年 | 156篇 |
2009年 | 109篇 |
2008年 | 202篇 |
2007年 | 197篇 |
2006年 | 182篇 |
2005年 | 171篇 |
2004年 | 140篇 |
2003年 | 122篇 |
2002年 | 133篇 |
2001年 | 85篇 |
2000年 | 84篇 |
1999年 | 74篇 |
1998年 | 29篇 |
1997年 | 33篇 |
1996年 | 25篇 |
1995年 | 20篇 |
1994年 | 20篇 |
1993年 | 18篇 |
1992年 | 41篇 |
1991年 | 40篇 |
1990年 | 34篇 |
1989年 | 34篇 |
1988年 | 27篇 |
1987年 | 22篇 |
1986年 | 27篇 |
1985年 | 25篇 |
1984年 | 20篇 |
1983年 | 15篇 |
1979年 | 16篇 |
1976年 | 15篇 |
1975年 | 13篇 |
1974年 | 19篇 |
1973年 | 32篇 |
1970年 | 17篇 |
1969年 | 14篇 |
1968年 | 11篇 |
1967年 | 11篇 |
排序方式: 共有4544条查询结果,搜索用时 31 毫秒
1.
2.
Ramya C. Mosarla Muthiah Vaduganathan Arman Qamar Javid Moslehi Gregory Piazza Robert P. Giugliano 《Journal of the American College of Cardiology》2019,73(11):1336-1349
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke prevention in patients with atrial fibrillation (AF). More recently, direct oral anticoagulants (DOACs) have been demonstrated to reduce the risk of venous and arterial thromboembolism in large randomized clinical trials of patients with VTE and AF, respectively, thus providing an attractive oral dosing option that does not require routine laboratory monitoring. In this review, we summarize available clinical trial data and guideline recommendations, and outline a practical approach to anticoagulation management of VTE and AF in cancer. 相似文献
3.
4.
5.
6.
Sameer Arora Kamal Shemisa Muthiah Vaduganathan Arman Qamar Ankur Gupta Sushil K. Garg Dharam J. Kumbhani Helen Mayo Houman Khalili Ambarish Pandey Sandeep R. Das 《Journal of the American College of Cardiology》2019,73(19):2454-2464
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects such as bleeding and dyspnea have been associated with premature ticagrelor discontinuation, which may limit any potential advantage of ticagrelor over clopidogrel. The randomized trials of ticagrelor captured adverse events, offering the opportunity to more precisely quantify these effects across studies. Therefore, a meta-analysis of 4 randomized clinical trials of ticagrelor conducted between January 2007 and June 2017 was performed to quantify the incidence and causes of premature ticagrelor discontinuation. Among 66,870 patients followed for a median 18 months, premature ticagrelor discontinuation was seen in 25%; bleeding was the most common cause of discontinuation followed by dyspnea. Versus the comparators, the relative risk of dyspnea-related discontinuation during follow-up was 6.4-fold higher, the relative risk of bleeding was 3.2-fold higher, and the relative risk of discontinuation due to any adverse event was 59% higher for patients receiving ticagrelor. Understanding these potential barriers to adherence to ticagrelor is crucial for informed patient-physician decision making and can inform future efforts to improve ticagrelor adherence. This review discusses the incidence, causes, and biological mechanisms of ticagrelor-related adverse effects and offers strategies to improve adherence to ticagrelor. 相似文献
7.
K Mahmood M N Chowdhury E A Ayoola I A Mofleh R S Rashed F Z Faleh 《Tropical gastroenterology》1991,12(4):188-191
Seventy seven antral biopsies were collected from patients attending endoscopy clinic at King Khalid University Hospital, Riyadh, Saudi Arabia during a period of six months between December 1988 to May 1989. Of these 69 (89.6%) showed chronic gastritis as well as Helicobacter-like organisms (HLOs) in the biopsy specimens while 63 (81.8%) of biopsies grew Helicobacter pylori on culture. These findings indicate a good correlation between the histological diagnosis of chronic gastritis and isolation of H. pylori on culture. 相似文献
8.
9.
10.
Regulation of ketogenesis, gluconeogenesis, and glycogen synthesis by insulin and proinsulin in rat hepatocyte monolayer cultures 总被引:5,自引:0,他引:5
The metabolic actions of porcine insulin and biosynthetic human proinsulin on fatty acid and glucose metabolism were studied in rat hepatocytes cultured in monolayer for 24 h. Our aim was to establish whether proinsulin action in the liver is similar to insulin action and whether the relative potencies of the two hormones are the same for different metabolic processes. Proinsulin and insulin exerted a similar maximal inhibitory effect on ketone body formation from palmitate and on gluconeogenesis from pyruvate. The half-maximal effective concentration of proinsulin was 11-13 times that of insulin. The antiketogenic effects of insulin and proinsulin were associated with an increased glycerol 3-phosphate content and a decreased affinity of carnitine palmitoyltransferase for its substrate palmitoyl-CoA. When the basal rate of ketogenesis was increased with isobutyl methylxanthine, the half-maximal effective concentrations of both proinsulin and insulin were decreased, but the relative potency of the two hormones was unchanged. Proinsulin and insulin exerted similar maximal stimulatory effects on glycogen synthesis and on the activities of pyruvate kinase, glucose 6-phosphate dehydrogenase, phosphogluconate dehydrogenase, and malic enzyme. The half-maximal effective concentration of proinsulin was 10-30 times that of insulin. These findings are consistent with receptor binding studies on liver membranes that suggest that proinsulin interacts with insulin-specific and not proinsulin-specific receptors. Our findings also suggest that proinsulin action does not differ from insulin action at a postreceptor site. 相似文献